Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
| ▸ | PRNP | P04156 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18877078 | 0.93 | CASP1 (0.34) | CASP1HSD17B10HRH4PRNPRXFP1 | |
| SCHEMBL19544386 | 0.92 | HSD17B10 (0.34) | CASP1HSD17B10HRH4PRNPRXFP1 | |
| SCHEMBL19544383 | 0.90 | HSD17B10 (0.33) | CASP1HSD17B10HRH4RXFP1KDM4E | |
| SCHEMBL21709121 | 0.88 | CASP1 (0.34) | CASP1HSD17B10HRH4RXFP1KDM4E | |
| SCHEMBL19544382 | 0.85 | TP53 (0.32) | RXFP1ALDH1A1HTTHPGDPDE10A | |
| SCHEMBL16856047 | 0.85 | HSD17B10 (0.35) | CASP1HSD17B10HRH4PRNPRXFP1 | |
| SCHEMBL19544063 | 0.85 | PTGES (0.32) | KDM4E | |
| SCHEMBL24036851 | 0.84 | HSD17B10 (0.39) | CASP1HSD17B10HRH4RXFP1KDM4E | |
| SCHEMBL22479780 | 0.84 | CASP1 (0.34) | CASP1HSD17B10HRH4RXFP1KDM4E | |
| SCHEMBL20989138 | 0.84 | L3MBTL1 (0.36) | KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180102486-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180102486-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, TRPV2 | CASP1 1837/4885HSD17B10 4538/4885HRH4 4114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.